3Tong X, O'Kelly J, Xie D, et al. CYR61 suppresses the growth of non small-cell lung cancer cells via the beta-cateninc-myc-p53 pathway[J]. Oncogene, 2004, 23(28) :4847-4855.
4Zhang Y, Talalay P, Cho CG, et al. A major inducer of anti- carcinogenic protective enzymes from broccoli: isolation and elucidation of structure [J]. Proc Natl Acad Sci USA, 1992, 89(6) : 2399 -2403.
5ZhangY, TalalayP. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes [J]. Cancer Res, 1998, 58(20): 4632-4639.
6BastenGP, BaoY, Williamson G. Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP glucuronosyl transferase (UGTIA1) and glutathione transferase (GS2TA1) incultured cells [J]. Carcinogenesis, 2002, 23(8): 1399- 1404.
7McMahonM, hohK, YamamotoM, el al. The Cap n'Collar basic leucine zipper transcription factor Nrf2 (NF E2p45 related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic en zymes[J]. Cancer Res, 2001, 61 (8) : 3299 -3307.
8Thimmmlappa RK, Mai KH, Srisuma S, et al. Identification of Nrf-2 regulated Genes Induced by the Chemopreventive Agent Sulforaphane by Oiigonucleotide Microarray [J]. Cancer Res, 2002, 62(18): 5196 -5203.
9Ye L. Zhang Y. Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of phase 2 detoxieation enzymes [J]. Carcinogenesis, 2001, 22(12): 1987- 1992.
10Johnston N. Sulforaphane halts breast cancer cell growth [J]. Drug Discov Today, 2004, 9(21 ): 908.
